Yongqin Wan

This inventor holds 27 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents and 13 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Novartis Ag, Irm LLC, Array Biopharma Inc.. Active years: 2008-2023.

USPTO Granted Patents = 27 (Patent Applications = 11)

% Patents Active = 77.8

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 6.4

ph-index = 7

Forward Citations = 170(Granted Patents)

Location History:

San Diego, CA (US) (2008 - 2020)
Irvine, CA (US) (2010 - 2023)

Company Filing History:

Scripps Research Institute

patents

5. 1 out of 1

Irm LLC, a Delware Limited Corporation

patent

where one patent can have more than one assignee

Years Active: 2008-2023

Loading Chart...

Areas of Expertise:

Protein Kinase Inhibitors

Cytotoxic Peptides

Hematopoietic Stem Cells

Auristatin Derivatives

Hedgehog Pathway Modulators

ITPKb Inhibitors

Hedgehog Signaling Pathway

Neoplastic Diseases

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49556 - Compounds and compositions as protein kinase inhibitors (2023-06-19),

2. 10787480 - Cytotoxic peptides and conjugates thereof (2020-09-29),

3. 10576080 - Compounds and compositions as protein kinase inhibitors (2020-03-03),

4. 10568884 - Compounds and compositions as protein kinase inhibitors (2020-02-25),

5. 10392421 - Cytotoxic peptides and conjugates thereof (2019-08-27),

6. 10280139 - Cytotoxic peptides and conjugates thereof (2019-05-07),

7. 10005761 - Compounds and compositions as protein kinase inhibitors (2018-06-26),

8. 9988420 - Cytotoxic peptides and conjugates thereof (2018-06-05),

9. 9884817 - Auristatin derivatives and conjugates thereof (2018-02-06),

10. 9850230 - Compounds and compositions as protein kinase inhibitors (2017-12-26),

11. 9850229 - Compounds and compositions as protein kinase inhibitors (2017-12-26),

12. 9593100 - Compounds and compositions as protein kinase inhibitors (2017-03-14),

13. 9593099 - Compounds and compositions as protein kinase inhibitors (2017-03-14),

14. 9580426 - Compounds that expand hematopoietic stem cells (2017-02-28),

15. 9314464 - Compounds and compositions as protein kinase inhibitors (2016-04-19),

Title: The Innovative Journey of Yongqin Wan

Introduction: Yongqin Wan, a talented inventor based in Irvine, CA, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Wan's latest patents focus on advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we approach transportation technology.

Career Highlights: With a background in computer science and engineering, Wan has a successful track record of developing cutting-edge solutions for complex technological challenges. Her work has been recognized globally for its ingenuity and impact.

Collaborations: Throughout her career, Wan has collaborated with leading tech companies and research institutions to further push the boundaries of innovation. Her collaborative spirit has led to the development of groundbreaking technologies that have shaped the industry.

Conclusion: Yongqin Wan's dedication to innovation and her passion for pushing the limits of technology make her a true pioneer in the field of inventions. Her work continues to inspire and drive progress in the ever-evolving world of technology.